Canara HSBC Life IPO Subscribed 6% on Day 1

By By Rediff Money Desk, New Delhi
Oct 10, 2025 13:07
Canara HSBC Life Insurance IPO received tepid response, subscribed only 6% on day 1. IPO details, price band, and OFS details.
Illustration: Dominic Xavier/Rediff.com
New Delhi, Oct 10 (PTI) The initial share sale of Canara HSBC Life Insurance received a muted response from investors, garnering just 6 per cent subscription on the first day of bidding on Friday.

The company's IPO received bids for 92,46,020 shares against 16,67,15,000 shares on offer, according to details available with the NSE till 12:57 pm.

The retail individual investors (RIIs) category was subscribed 9 per cent, and the portion for non-institutional investors received 3 per cent. The qualified institutional buyers (QIBs) category did not see any participation so far.

On Thursday, Canara HSBC Life Insurance Company raised a little over Rs 750 crore from anchor investors.

The Rs 2,516-crore maiden public offering of the insurer will conclude on October 14.

The company has set a price band of Rs 100 to Rs 106 per share for its IPO, targeting a valuation of about Rs 10,000 crore at the upper end.

Canara HSBC Life Insurance Company is a joint venture promoted by Canara Bank, which holds a 51 per cent stake, and HSBC Group's HSBC Insurance (Asia Pacific) Holdings, which owns 26 per cent.

Canara HSBC Life's IPO is a complete offer for sale (OFS) of 23.75 crore equity shares by promoters and an investor.

Under the OFS, Canara Bank will sell 13.77 crore equity shares, HSBC Insurance (Asia-Pacific) Holdings Ltd will offload 47.5 lakh shares, and Punjab National Bank plans to divest 9.5 crore equity shares.

Since it's an OFS, the company will not receive any proceeds from the public issue; instead, funds will go to selling shareholders.

Incorporated in 2007, Canara HSBC Life has grown into a prominent bank-led private player in the Indian life insurance sector.

In terms of issue allocation, 50 per cent of the IPO is reserved for qualified institutional buyers (QIBs), 35 per cent for retail investors, and the remaining 15 per cent for non-institutional investors. Further, investors can bid for a minimum of 140 shares and in multiples thereof.

Canara HSBC Life is expected to make its stock market debut on October 17.

In December 2024, Canara Bank announced that it had received the Reserve Bank's approval for a proposal to divest the bank's stake in life insurance and mutual fund ventures. PTI HG


HG
Source: PTI
Read More On:
ipo subscriptionoffer for sale (ofs)canara bankhsbc insurancecanara hsbc life ipo
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.

You May Like To Read

MORE NEWS

PSB Recruitment Streamlined: FinMin Initiatives

Finance Ministry streamlines recruitment for public sector banks (SBI, NBs, RRBs)....

Sensex Jumps 427 Pts: Metal, Auto Shares Boost...

Sensex and Nifty rebound after a 3-day slide. Buying in metal and auto stocks, plus a...

India-EU Free Trade Agreement: Goyal Optimistic

Piyush Goyal expresses confidence in finalizing the India-EU free trade agreement....

Rupee Hits Record Low: 90.33 Against US Dollar

Rupee slumps to all-time low of 90.33 against the US dollar amid India-US trade deal...

FarEye Revenue Up 26% to Rs 197.5 Cr in FY25

FarEye reports 26% revenue growth to Rs 197.5 Cr in FY25. EBITDA improves 57%. Company...

AI Copyright: DPIIT Panel to Release 2nd Paper

DPIIT committee to release 2nd paper on copyrightability of AI-generated content. Focus...

AI Copyright: DPIIT Panel to Release 2nd Paper

DPIIT committee to release 2nd paper on copyrightability of AI-generated content....

HCC Transfers Rs 2,854 Cr Debt to PRPL

HCC transfers Rs 2,854 crore debt to Prolific Resolution Pvt Ltd (PRPL). Reduces debt...

HCC Transfers Rs 2,854 Cr Debt to PRPL

HCC transfers Rs 2,854 crore debt to Prolific Resolution Pvt Ltd (PRPL), reducing debt...

Glenmark Launches Generic Anemia Drug in US

Glenmark Pharmaceuticals to launch generic Leucovorin Calcium injection in the US for...

Read More »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2025 Rediff.com